Argenta Silver Corp. sees its stock decline following the announcement of a new mineral discovery at its El Quevar project in Argentina and the completion of a substantial equity financing, highlighting the complex calculus investors face with junior mining explorers.
Prime Minister Keir Starmer's landmark visit to Beijing marks a cautious pivot in UK-China relations, yielding agreements on tariffs, visas, and green energy. But can British businesses navigate the opportunities and challenges of re-engagement?
Despite bearing the brunt of costly natural disasters, Asia-Pacific remains the world's least insured region, with a staggering $64 billion protection shortfall in 2024 alone, threatening economic stability and vulnerable communities.
A disappointing full-year EBITDA performance from its crucial Macau operations triggered a sharp sell-off in Las Vegas Sands stock, underscoring the lingering challenges facing the gaming giant in the wake of China's regulatory crackdown.
As cautious optimism returns to Australian markets, investors are scanning the small-cap space for resilient companies with growth potential. We examine three ASX-listed firms, each with a market capitalisation below $700 million, that stand out for their financial health and strategic positioning.
Mortgage insurance provider MGIC Investment Corp. (NYSE: MTG) reported fourth-quarter revenue that missed analyst expectations, highlighting challenges in a cooling housing market. While earnings per share met consensus, flat year-over-year sales growth disappointed investors.
With interest rates in flux and inflation still outpacing many high street offers, finding a competitive home for your cash is crucial. We break down the top accounts across all categories to help your savings work harder.
Security forces are engaged in extensive operations across Balochistan following a devastating wave of coordinated assaults by separatist militants on civilian and government targets over the weekend, which killed nearly 50 people and marked a significant escalation in the long-running conflict.
While the FTSE 100 grapples with global headwinds, a segment of smaller UK-listed companies presents distinct opportunities. We examine three firms, each with a market capitalisation over £90 million, that combine financial resilience with specific growth catalysts.
As Ingredion prepares to release its fourth-quarter results, investors are weighing whether the company can stabilize after a disappointing prior quarter. The broader staples sector's recent strength offers a cautiously optimistic backdrop.
While the frequency of U.S. government shutdowns has declined since the 1990s, a deepening partisan divide has transformed them into longer, more damaging stalemates, with 22 closures since 1976 imposing growing costs on federal operations and the public.
Last week's sharp sell-off in BCI Minerals wiped AU$103 million from its market value, with private companies and institutional investors, who collectively control nearly 70% of the stock, feeling the deepest pain. The drop raises questions about shareholder influence and the company's near-term outlook.
As Silver Storm Mining prepares to take the stage at the Vancouver Resource Investment Conference, investors are weighing its staggering 174% three-month surge against a premium valuation and no revenue. The spotlight is on CEO Gregory McKenzie to convince the market the story is worth the price.
Rights groups document a disturbing pattern of Iranian security forces raiding hospitals to arrest injured protesters and the medical personnel treating them, transforming sanctuaries of care into sites of fear and reprisal.
Investor Kevin O'Leary argues that rigid return-to-office policies are a competitive disadvantage, pushing high performers toward flexible employers and leaving companies with a diminished talent pool.
Electro Optic Systems (EOS), the Australian firm behind a landmark high-energy laser contract, is planning a strategic move of its headquarters and listing to Europe within the year, its CEO reveals, aiming to embed itself at the heart of the continent's urgent defence modernisation drive.
As Eli Lilly prepares to report its Q4 and full-year 2025 results on February 4th, investors are weighing whether the pharmaceutical giant's premium valuation leaves room for a positive surprise, or if the stock is priced for perfection.
Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
United States Antimony (UAMY) faces a volatile market reaction following Washington's reported reversal on critical mineral price supports, casting uncertainty over its strategic expansion into Bolivia.
While Alpha IVF Group Berhad's latest earnings disappointed the market, a deeper look reveals a significant accrual ratio, raising questions about the quality of its profits and the sustainability of its cash generation.
